<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01531062</url>
  </required_header>
  <id_info>
    <org_study_id>Nigella sativa</org_study_id>
    <nct_id>NCT01531062</nct_id>
  </id_info>
  <brief_title>Effect of Nigella Sativa on Lipid Profiles in Elderly</brief_title>
  <official_title>Effect of Nigella Sativa on Lipid Profiles in Elderly: a Randomized Double-blinded Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Nigella sativa seed extracts are effective
      in the treatment of dyslipidemia in elderly.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular diseases are still common health problems worldwide. They are major causes of
      morbidity and mortality in many countries. Dyslipidemia is the main risk factor of
      cardiovascular events. Despite the invention of many conventional hypolipidemic drugs, the
      use of traditional medicine remains high, especially in elderly patients. However, evidence
      of the effectiveness of many herbs or other traditional drugs is lacking. Nigella sativa or
      black seeds are traditional herbs used for years in Middle East and India. They are believed
      to cure many diseases, including dyslipidemia. Therefore, a study is needed to prove their
      effectiveness as their use might improve our strategy to improve patients' compliance.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decreased level of total cholesterol, LDL, dan triglyceride, and increased level of HDL</measure>
    <time_frame>56 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Dyslipidemia</condition>
  <arm_group>
    <arm_group_label>Nigella sativa</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nigella sativa extracts, 300 mg twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nigella sative</intervention_name>
    <description>Nigella sativa seed extracts, 300 mg capsule bid, for 56 days</description>
    <arm_group_label>Nigella sativa</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>black sticky rice</intervention_name>
    <description>300 mg capsule bid, 56 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age of 60 years or more

          -  having dyslipidemia (total cholesterol &gt;200 mg/dL or LDL &gt;100 mg/dL or triglyceride &gt;
             150 mg/dL or HDL &lt; 40 mg/dL (male) or HDL &lt; 50 mg/dL (female)

        Exclusion Criteria:

          -  ALT or AST are two times of upper normal limit

          -  creatinine clearance test is below 30
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Internal Medicine Department, Faculty of Medicine, University Indonesia</name>
      <address>
        <city>Jakarta</city>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2012</study_first_submitted>
  <study_first_submitted_qc>February 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2012</study_first_posted>
  <last_update_submitted>February 8, 2012</last_update_submitted>
  <last_update_submitted_qc>February 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Jimmy Tandradynata</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>nigella sativa</keyword>
  <keyword>dyslipidemia</keyword>
  <keyword>elderly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

